Rocket Pharmaceuticals Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript
Good morning, and welcome to the second day of Chardan Genetic Medicines and Cell Therapy Manufacturing Summit. I'm Geulah Livshits, and our compliance team has asked me to read this statement for today's session.
By participating in this event, our speakers attest that they have made certain aware of any potential conflicts, and they will not discuss any material non-public or confidential information that they're aware of that may breach their legal, regulatory, or fiduciary responsibility to any party.
So with that done, it's now my pleasure to introduce Dr. Kinnari Patel, President and Chief Operating Officer of Rocket Pharma. The format for this session is roughly a 25-minute fireside chat. If you have any questions in the session, feel free to take them into the question box.
Questions & Answers
So Kinnari, thank you for joining us. To start, could you please discuss Rocket's manufacturing capabilities and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |